Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biotechnol Bioeng ; 107(4): 683-95, 2010 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-20589846

RESUMO

Mouse embryonic stem cell (ESC) lines, and more recently human ESC lines, have become valuable tools for studying early mammalian development. Increasing interest in ESCs and their differentiated progeny in drug discovery and as potential therapeutic agents has highlighted the fact that current two-dimensional (2D) static culturing techniques are inadequate for large-scale production. The culture of mammalian cells in three-dimensional (3D) agitated systems has been shown to overcome many of the restrictions of 2D and is therefore likely to be effective for ESC proliferation. Using murine ESCs as our initial model, we investigated the effectiveness of different 3D culture environments for the expansion of pluripotent ESCs. Solohill Collagen, Solohill FACT, and Cultispher-S microcarriers were employed and used in conjunction with stirred bioreactors. Initial seeding parameters, including cell number and agitation conditions, were found to be critical in promoting attachment to microcarriers and minimizing the size of aggregates formed. While all microcarriers supported the growth of undifferentiated mESCs, Cultispher-S out-performed the Solohill microcarriers. When cultured for successive passages on Cultispher-S microcarriers, mESCs maintained their pluripotency, demonstrated by self-renewal, expression of pluripotency markers and the ability to undergo multi-lineage differentiation. When these optimized conditions were applied to unweaned human ESCs, Cultispher-S microcarriers supported the growth of hESCs that retained expression of pluripotency markers including SSEA4, Tra-1-60, NANOG, and OCT-4. Our study highlights the importance of optimization of initial seeding parameters and provides proof-of-concept data demonstrating the utility of microcarriers and bioreactors for the expansion of hESCs.


Assuntos
Reatores Biológicos , Biotecnologia/métodos , Células-Tronco Embrionárias , Animais , Técnicas de Cultura de Células/métodos , Humanos , Camundongos , Microesferas
2.
Plant J ; 44(2): 290-9, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16212607

RESUMO

The mitotic inducer gene from Schizosaccharomyces pombe, Spcdc25, was used as a tool to investigate regulation of G2/M in higher plants using the BY-2 (Nicotiana tabacum) cell line as a model. Spcdc25-expressing BY-2 cells exhibited a reduced mitotic cell size through a shortening of the G2 phase. The cells often formed isodiametric double files both in BY-2 cells and in cell suspensions derived from 35S::Spcdc25 tobacco plants. In Spcdc25-expressing cells, the tobacco cyclin-dependent kinase, NtCDKB1, showed high activity in early S phase, S/G2 and early M phase, whereas in empty vector cells CDKB1 activity was transiently high in early S phase but thereafter remained lower. Spcdc25-expressing cells also bypassed a block on G2/M imposed by the cytokinin biosynthetic inhibitor lovastatin (LVS). Surprisingly, cytokinins were at remarkably low levels in Spcdc25-expressing cells compared with the empty vector, explaining why these cells retained mitotic competence despite the presence of LVS. In conclusion, synchronised Spcdc25-expressing BY-2 cells divided prematurely at a small cell size, and they exhibited premature, but sustained, CDKB1 activity even though endogenous cytokinins were virtually undetectable.


Assuntos
Proteínas de Ciclo Celular/metabolismo , Divisão Celular , Proteínas Fúngicas/metabolismo , Fase G2 , Nicotiana/citologia , Nicotiana/genética , Proteínas de Schizosaccharomyces pombe/metabolismo , ras-GRF1/metabolismo , Afidicolina/farmacologia , Proteínas de Ciclo Celular/genética , Divisão Celular/efeitos dos fármacos , Tamanho Celular , Células Cultivadas , Quinases Ciclina-Dependentes/metabolismo , Proteínas Fúngicas/genética , Fase G2/efeitos dos fármacos , Regulação da Expressão Gênica de Plantas , Lovastatina/farmacologia , Proteínas de Plantas/metabolismo , Plantas Geneticamente Modificadas , Schizosaccharomyces , Proteínas de Schizosaccharomyces pombe/genética , Transdução de Sinais , Nicotiana/efeitos dos fármacos , Nicotiana/metabolismo , ras-GRF1/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...